首页 | 本学科首页   官方微博 | 高级检索  
     


Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones
Authors:Cheryl Dambrot  Henk P.J. Buermans  Eszter Varga  Georgios Kosmidis  Karin Langenberg  Simona Casini  David A. Elliott  Andras Dinnyes  Douwe E. Atsma  Christine L. Mummery  Stefan R. Braam  Richard P. Davis
Affiliation:1. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands;2. Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands;3. Leiden Genome Technology Center, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands;4. BioTalentum Ltd., Gödöllö, Hungary;5. Molecular Animal Biotechnology Laboratory, Szent Istvan University, Gödöllö, Hungary;6. Pluriomics B.V., Leiden, The Netherlands;g Murdoch Childrens Research Institute, The Royal Children’s Hospital, Parkville, VIC, Australia;h Netherlands Proteomics Institute, Utrecht, The Netherlands
Abstract:Recent methodological advances have improved the ease and efficiency of generating human induced pluripotent stem cells (hiPSCs), but this now typically results in a greater number of hiPSC clones being derived than can be wholly characterized. It is therefore imperative that methods are developed which facilitate rapid selection of hiPSC clones most suited for the downstream research aims. Here we describe a combination of procedures enabling the simultaneous screening of multiple clones to determine their genomic integrity as well as their cardiac differentiation potential within two weeks of the putative reprogrammed colonies initially appearing. By coupling splinkerette-PCR with Ion Torrent sequencing, we could ascertain the number and map the proviral integration sites in lentiviral-reprogrammed hiPSCs. In parallel, we developed an effective cardiac differentiation protocol that generated functional cardiomyocytes within 10 days without requiring line-specific optimization for any of the six independent human pluripotent stem cell lines tested. Finally, to demonstrate the scalable potential of these procedures, we picked 20 nascent iPSC clones and performed these independent assays concurrently. Before the clones required passaging, we were able to identify clones with a single integrated copy of the reprogramming vector and robust cardiac differentiation potential for further analysis.
Keywords:Human induced pluripotent stem cell   Cell differentiation   Cardiomyocytes   High-throughput DNA sequencing
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号